Original BioMedicals Co., Ltd. (TPEX:6483)

Market Cap	1.04B +48.0%
Revenue (ttm)	381.00K +786.0%
Net Income	-90.30M
EPS	-1.37
Shares Out	66.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	734,179
Average Volume	325,366
Open	15.45
Previous Close	15.45
Day's Range	15.45 - 15.70
52-Week Range	9.12 - 16.15
Beta	0.08
RSI	68.80
Earnings Date	Mar 27, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Employees: 23
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6483